Sunshine Lake Pharma Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Millions HKD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 17, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	19,733	26,274	8,412	8,351	5,720	5,368
Market Cap Growth	70.40%	212.32%	0.74%	46.00%	6.56%	-30.92%
Enterprise Value	23,261	34,991	9,289	9,299	9,130	7,738
Last Close Price	34.26	45.60	32.84	32.60	22.33	20.95
PE Ratio	55.98	86.66	-	3.80	66.05	-
PS Ratio	3.68	4.90	1.97	1.20	1.35	4.79
PB Ratio	4.09	5.44	1.77	0.96	0.83	0.73
P/TBV Ratio	6.20	8.25	-	1.41	1.71	1.19
P/FCF Ratio	55.56	73.98	-	5.70	4.48	-
P/OCF Ratio	15.35	20.44	15.79	4.53	2.98	-
EV/Sales Ratio	4.34	6.53	2.17	1.34	2.16	6.90
EV/EBITDA Ratio	18.13	28.61	11.94	2.66	11.68	-
EV/EBIT Ratio	30.24	45.49	24.33	3.03	25.02	-
EV/FCF Ratio	65.50	98.53	-	6.35	7.15	-
Debt / Equity Ratio	1.08	1.08	1.03	0.33	0.63	0.53
Debt / EBITDA Ratio	4.06	4.06	5.95	0.82	5.46	-
Debt / FCF Ratio	14.66	14.66	-	1.96	3.38	-
Net Debt / Equity Ratio	0.73	0.73	0.70	0.12	0.43	0.34
Net Debt / EBITDA Ratio	2.89	2.89	4.30	0.30	3.77	-9.98
Net Debt / FCF Ratio	9.96	9.96	-5.59	0.70	2.31	-2.02
Asset Turnover	0.40	0.40	0.33	0.51	0.33	0.09
Inventory Turnover	1.49	1.49	1.68	3.62	3.02	1.31
Quick Ratio	0.56	0.56	0.70	0.87	0.46	1.36
Current Ratio	0.77	0.77	1.03	1.40	1.01	1.66
Return on Equity (ROE)	6.13%	6.13%	0.40%	26.50%	0.81%	-10.57%
Return on Assets (ROA)	3.61%	3.61%	1.82%	14.16%	1.80%	-2.85%
Return on Invested Capital (ROIC)	5.65%	5.62%	0.77%	27.75%	3.85%	-6.47%
Return on Capital Employed (ROCE)	11.60%	11.60%	5.00%	33.20%	4.60%	-4.90%
Earnings Yield	1.54%	1.15%	-2.62%	26.29%	1.51%	-13.44%
FCF Yield	1.80%	1.35%	-7.10%	17.54%	22.33%	-23.30%
Payout Ratio	214.52%	214.52%	-	-	-	-
Buyback Yield / Dilution	-13.00%	-13.00%	-90.10%	-	-	20.42%
Total Shareholder Return	3.50%	-13.00%	-90.10%	-	-	20.42%